In addition, local administration of CpG-ODN can significantly increase the production of pro-inflammatory chemokines and cytokines, such as IP10, MIP1β, MCP5, MIP1, RANTES, JE, MCP5 and MIP1α, which play a role in the observed anti-tumour effects [9]. The gene discussed is CCL5; the disease is neoplasm.